Stay updated on Radiation+Chemo+Ipilimumab+Nivolumab in Stage III NSCLC Clinical Trial

Sign up to get notified when there's something new on the Radiation+Chemo+Ipilimumab+Nivolumab in Stage III NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Radiation+Chemo+Ipilimumab+Nivolumab in Stage III NSCLC Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The page shows a revision tag updated from v3.5.3 to v3.5.4, representing an internal site version update rather than a change to the trial information.
    Difference
    0.2%
    Check dated 2026-05-15T23:59:34.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    The page revision indicator was updated from v3.5.2 to v3.5.3, reflecting a system/version change without affecting the underlying study record content.
    Difference
    0.1%
    Check dated 2026-04-24T16:56:52.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T13:45:39.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    Revision label on the page updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-19T23:50:51.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.2 to v3.4.3 on the page.
    Difference
    0.1%
    Check dated 2026-03-12T21:29:12.000Z thumbnail image
  8. Check
    97 days ago
    Change Detected
    Summary
    Revision updated to v3.4.2, replacing the prior v3.4.1.
    Difference
    0.1%
    Check dated 2026-02-12T01:50:17.000Z thumbnail image

Stay in the know with updates to Radiation+Chemo+Ipilimumab+Nivolumab in Stage III NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Radiation+Chemo+Ipilimumab+Nivolumab in Stage III NSCLC Clinical Trial page.